| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |